Home Spirometry for Post-COVID Recovery: A Clinical Validation Study of an Ultrasonic Device
Authors:
Open Access
- 30 May 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (11) , 1396
Abstract
Background/Objectives: Patients recovering from COVID-19 often experience persistent respiratory symptoms, necessitating pulmonary function monitoring. While clinical spirometry is the gold standard, home spirometry offers a remote alternative. This study evaluated the validity of an ultrasonic home-based spirometer for monitoring lung function in post-COVID-19 pneumonia patients over 12 weeks. Methods: This prospective study included 30 post-COVID pneumonia patients who underwent clinical spirometry at weeks 4, 8 and 12. Participants performed weekly home spirometry using the SpiroHome Personal® device. Agreement between home and clinical spirometry was assessed using a Bland–Altman analysis, intraclass correlation coefficients (ICCs), and Pearson correlation coefficients. Pulmonary function changes over time were analyzed using repeated measures ANOVA. Results: Home spirometry showed strong agreement with clinical spirometry for forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1), with ICC values exceeding 0.92. The Bland–Altman analysis demonstrated minimal bias, though limits of agreement exceeded the clinically accepted threshold of ±150 mL. FEV1/FVC ratios showed greater variability. Pulmonary function improved significantly over 12 weeks for both methods (p < 0.002). Patient adherence to home spirometry remained high, with a median of 18.50 sessions [IQR: 15.00–26.00] and an overall compliance rate of 98.33% ± 9.13%. Conclusions: Home spirometry provides reliable pulmonary function measurements, particularly for FVC and FEV1, supporting its role as a remote monitoring tool. Despite minor variability in FEV1/FVC, home spirometry enables frequent assessment of lung function recovery, potentially reducing hospital visits and improving patient management.Keywords
Funding Information
- Inofab Health Technologies
This publication has 38 references indexed in Scilit:
- Clinic vs Home Spirometry for Monitoring Lung Function in Patients With AsthmaChest, 2023
- Regarding the articles on home spirometryJournal of Cystic Fibrosis, 2022
- Quality of home spirometry performance amongst adults with cystic fibrosisJournal of Cystic Fibrosis, 2022
- A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosisJournal of Cystic Fibrosis, 2021
- Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal studyClinical Microbiology and Infection, 2021
- Post-ICU COVID-19 OutcomesChest, 2021
- Airborne Particulate Concentrations During and After Pulmonary Function TestingChest, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recoveryeClinicalMedicine, 2020
- Comparison of a handheld turbine spirometer to conventional spirometry in children with cystic fibrosisPediatric Pulmonology, 2020